Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 4, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • FEATURED
  • Are you resistant after recovery from Covid-19?

Do microRNAs and environmental factors aid in the formation of a cleft-lip/palate?

Focus Area Science Technology Summer Fellowship 2021 – [FAST-SF]

Are you resistant after recovery from Covid-19?
  • BiotechToday
  • FEATURED
  • India
  • Latest

Are you resistant after recovery from Covid-19?

bioxone September 15, 2020September 14, 2020

-Mayukh Sinha, Amity University Kolkata

The COVID-19 pandemic is the trending matter of concern. In addition to that, the post-recovery health of COVID-19 patients has imposed a threat as well. It has been reported that a 33-year-old Chinese man caught his second infection. It simply posed a doubt on the human immune system’s ability to combat pathogens harmful to it.

The human immune system works in two ways: Firstly, the innate immunity (immediate work of action) and secondly, the adaptive immunity (slowly acquiring by the bodily process of combating the infection). In the case of adaptive Immunity, the T and B cells (W.B.Cs) detect and conduct target response. The T cells sense and kill the infected cells. On the other hand, B cells produce antibodies for the same. T and B cells are capable enough to retain their memory and combat the same infection in the future.

Recently, a published study in Nature Medicine states that the antibodies for the SARS-CoV-2 start to decrease after 2-3 months. Scientists from Chongqing Medical University added that they have observed a drastic decrease in the immunoglobulin-G (IgG) levels and neutralizing antibodies of recovered SARS-CoV-2 patients in a time period of 2-3 months.

Due to this decline in the number of antibodies, the immune system is unable to retain the memory of the infection, and thus in some cases, it is unable to protect the body in case of re-infection in the future.

Source:

1. https://www.thehindu.com/sci-tech/science/antibodies-against-coronavirus-start-to-decrease-in-2-3-months-study-finds/article31875553.ece

2. https://www.thehindu.com/sci-tech/health/the-hindu-explains-are-there-re-infection-fears-around-covid-19/article32590566.ece

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged corona corona in india corona virus coronaremedies Covid Covid 19 pandemic COVID INDIA COVID Re-infection COVID-19 hindu Nature Nature Medicine Re- infection recovery in COVID reinfection in covid The Hindu

2 thoughts on “Are you resistant after recovery from Covid-19?”

  1. Camelia Bhattacharyya says:
    September 15, 2020 at 4:42 am

    Very informative, compact and well-written.

    Reply
    1. Mayukh Sinha says:
      September 15, 2020 at 5:02 am

      Thank you for your valuable feedback.

      Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Latest
  • Signaling Pathway

Focus Area Science Technology Summer Fellowship 2021 – [FAST-SF]

bioxone September 15, 2020

–Shristi Sharma, Team bioXone With a view to enhancing the spread of Technology and Science at the specific regions of the Nation, the Inter-Academy Panel has Pioneered the Focus Area Science Technology Summer Fellowship [FAST-SF]. This coming year (2021) our attention will be on the North Eastern States of the Nation and the states of […]

Related Post

  • BiotechToday
  • India

E. coli enhancing the amount of copper in the environment

bioxone November 30, 2020November 29, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA Heavy metal collection from industrial wastes and agriculture is a long-standing challenge. This is more dangerous for copper since pollution from copper is unsafe for both the environment and for human health. The researchers, in this study, applied a two-way approach of Darwin’s theory of natural selection with bacterial bioengineering […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Job and Internship
  • Latest
  • Signaling Pathway

ICMR Recruitment Exam | Scientist – B Post |Up to Rs 1.78 Lakh Salary

bioxone September 15, 2020September 15, 2020

-Shristi Sharma, Team bioXone Biochemistry, Microbiology, Virology, Biotechnology, Molecular Biology, Biology/Bioscience, Zoology, Biostatistics, Bioinformatics applicants can apply for this. Check out all of the details on the same below: Advertisement No. ICMR/SC-B/2020 Indian Council of Medical Research (ICMR), New Delhi has entered into a memorandum of understanding with Postgraduate Institute of Medical Education & Research […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Corneal collagen cross-linking – a new way to treat keratoconus

BioTech Today July 26, 2021July 29, 2021

Shrestha Dutta, Amity University Kolkata Keratoconus is a continuous ectatic corneal disorder that gives rise to corneal stroma impedance and biomechanical weakening. Corneal collagen cross-connecting (CXL) is a powerful treatment to stop the growth of keratoconus. UV light of 3mW/cm2 is utilized in classic Dresden CXL for brightening and a single treatment technique needs 60 […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy